1,721,569 research outputs found
Fermentation Temperature Affects the Alteration of Functional Constituents in Bacillus subtilis BCRC 14715-fermented Black Soybean
本研究以黑豆為原料,接種Bacillus subtilis BCRC 14715進行固態發酵,探討不同發酵溫度 (35, 40, 45, 50°C) 於培養期間 (0, 6, 12, 18小時) 對黑豆中一些活性成分,包括異黃酮素、納豆激酶 (nattokinase) 、維生素K2、血管收縮素轉化酶抑制劑 (angiotensin- converting enzyme inhibitor, ACE inhibitor) 、超氧歧化酶 (superoxide dismutase, SOD) 及吡啶二羧酸 (dipicolinic acid, DPA) 變化之影響。 結果顯示,40及45°C為B. subtilis BCRC 14715在黑豆基質中之最適生長溫度。無論發酵溫度為何,黑豆之總異黃酮含量在發酵過程中皆逐漸降低,其中以在35℃下發酵者下降之趨勢最為顯著。經發酵後之黑豆,其醣苷配基 (aglycone) 形式之異黃酮素含量,隨發酵時間增長而有明顯上升之趨勢 (p<0.05),其中以在50°C下發酵之黑豆可獲得最高aglycone形式之異黃酮素。在各發酵溫度下,黑豆中β-葡萄醣苷酶 (β-glucosidase) 活性皆於發酵6小時達最大值,其後即呈下降之趨勢。此外,隨發酵時間延長,黑豆中納豆激酶活性、維生素K2含量、ACE inhibitor活性、SOD活性及DPA含量均逐漸提升。黑豆經發酵18小時後,以在35°C下發酵者可得最高之納豆激酶活性,維生素K2則是在45°C下發酵可獲得最大產量;黑豆於40及45°C下發酵可呈現較佳之ACE抑制活性及SOD活性;在50°C下發酵者,則可獲得最大之DPA產量。In the present study, fermented black soybean was prepared with Bacillus subtilis CRC 14715. The changes of some functional constituents of fermented black soybean, including isoflavone, nattokinase, vitamin K2, angiotensin- converting enzyme inhibitor (ACE), superoxide dismutase (SOD), and dipicolinic acid (DPA), during the fermentation (0, 6, 12, 18 h) with B. subtilis BCRC 14715 at various temperatures (35, 40, 45, 50°C) were investigated. The results revealed that the optimum growth temperatures of B. subtilis BCRC 14715 are 40-45°C in black soybean. The total content of isoflavone in black soybean decreased during fermentation, regardless of fermentation temperatures. The most marked change was observed at 35°C. Fermentation caused a significant increase (p<0.05) in the content of aglycone, which enhanced with fermentation time. The highest level of aglycone was obtained in black soybean fermented at 50°C. Regardless of fermentation temperatures, the activity of β-glucosidase noted in black soybean reached the highest after 6 h of fermentation and then decreased progressively. In addition, nattokinase activity, vitamin K2 content, ACE inhibitor activity, SOD activity and DPA content of black soybean increased as the fermentation time was extended. Black soybean fermented at 35°C for 18 h exhibited the highest level of nattokinase activity, while the highest content of vitamin K2 and DPA was found in black soybean fermented at 45 and 50°C, respectively. On the other hand, a higher activity of ACE inhibitor and SOD was observed in black soybean fermented at 40 and 45°C.摘要-------------------------------------------------------------------------------------------- ibstract---------------------------------------------------------------------------------------- ii錄-------------------------------------------------------------------------------------------- iii目錄----------------------------------------------------------------------------------------- vii目錄----------------------------------------------------------------------------------------- viii、前言-------------------------------------------------------------------------------------- 1、文獻整理-------------------------------------------------------------------------------- 2、黑豆----------------------------------------------------------------------------------- 21. 黑豆簡介------------------------------------------------------------------------------ 22. 黑豆之機能性------------------------------------------------------------------------ 2、納豆食品------------------------------------------------------------------------------ 3、納豆之活性成分--------------------------------------------------------------------- 41. 異黃酮--------------------------------------------------------------------------------- 4 2. 納豆激酶------------------------------------------------------------------------------ 63. 維生素K2----------------------------------------------------------------------------- 7 4. 血管收縮素轉化酶------------------------------------------------------------------ 7. 超氧歧化酶--------------------------------------------------------------------------- 8. 吡啶二羧酸--------------------------------------------------------------------------- 8. 發酵溫度對發酵製品的影響------------------------------------------------------ 9、材料與方法----------------------------------------------------------------------------- 11、實驗架構----------------------------------------------------------------------------- 11 二、實驗材料------------------------------------------------------------------------------ 11. 菌種------------------------------------------------------------------------------------ 11. 黑豆------------------------------------------------------------------------------------ 11. 培養基--------------------------------------------------------------------------------- 11. 試驗藥品------------------------------------------------------------------------------ 115. 儀器設備------------------------------------------------------------------------------ 14、B. subtilis BCRC 14715之保存活化及菌酛之製備---------------------------- 15. 菌株之保存--------------------------------------------------------------------------- 15. 菌種活化及菌酛之製備------------------------------------------------------------ 15 四、黑豆之發酵--------------------------------------------------------------------------- 16 五、分析方法------------------------------------------------------------------------------ 16. 菌數之測定--------------------------------------------------------------------------- 16 2. 異黃酮素之分析--------------------------------------------------------------------- 17 2.1. 發酵黑豆中異黃酮素之萃取方法-------------------------------------------- 17.2. 異黃酮素之分離----------------------------------------------------------------- 17.3. 異黃酮素標準曲線製作與發酵黑豆中異黃酮素之定量----------------- 17. β-glucosidase 活性之測定------------------------------------------------------- 18.1酵素液之製備---------------------------------------------------------------------- 18.2. 酵素活性之測定----------------------------------------------------------------- 18. 納豆激酶活性之測定--------------------------------------------------------------- 19.1萃取液之製備---------------------------------------------------------------------- 19 4.2 血纖維蛋白平板試驗法--------------------------------------------------------- 19 4.3 納豆激酶活性測定--------------------------------------------------------------- 19 5. 維生素K2之分析-------------------------------------------------------------------- 20 5.1維生素K2之萃取------------------------------------------------------------------ 20 5.2維生素K2之分離------------------------------------------------------------------ 20.3. 維生素K2標準曲線製作與發酵黑豆中維生素K2之定量--------------- 20. 血管收縮素轉化酶抑制劑之分析------------------------------------------------ 21.1萃取液之製備---------------------------------------------------------------------- 21.2 血管收縮素轉化酶抑制劑活性之測定--------------------------------------- 217. 超氧歧化酶之分析------------------------------------------------------------------ 22 7.1 萃取液之製備--------------------------------------------------------------------- 22 7.2 超氧歧化酶活性之測定--------------------------------------------------------- 22. 吡啶二羧酸之分析------------------------------------------------------------------ 22 8.1 萃取液之製備--------------------------------------------------------------------- 22.2 吡啶二羧酸含量之分析--------------------------------------------------------- 23. 統計分析------------------------------------------------------------------------------ 23、結果與討論----------------------------------------------------------------------------- 24、不同溫度下B. subtilis BCRC 14715於黑豆中之生長------------------------- 24、B. subtilis BCRC 14715發酵黑豆之異黃酮素含量---------------------------- 26. 不同溫度對B. subtilis BCRC 14715發酵黑豆總異黃酮含量之影響------ 26. B. subtilis BCRC 14715發酵黑豆過程中各異黃酮含量之變化------------- 28. 不同溫度對B. subtilis BCRC 14715發酵黑豆異黃酮組成之比較--------- 29 三、不同發酵溫度對B. subtilis BCRC 14715發酵黑豆β-葡萄醣苷酶活性之影響-------------------------------------------------------------------------------- 41 四、不同發酵溫度下B. subtilis BCRC 14715在黑豆中納豆激酶之產生------- 43 五、不同溫度對B. subtilis BCRC 14715發酵黑豆中維生素K2含量之影響---------------------------------------------------------------------------------------- 47、不同溫度對B. subtilis BCRC 14715發酵黑豆中血管收縮素轉化酶抑制之影響------------------------------------------------------------------------------ 49、不同溫度對B. subtilis BCRC 14715發酵黑豆中超氧歧化酶之影響------- 51、不同溫度對B. subtilis BCRC 14715發酵黑豆中吡啶二羧酸之影響------- 54、結論--------------------------------------------------------------------------------------- 56、參考文獻-------------------------------------------------------------------------------- 57錄一----------------------------------------------------------------------------------------- 69圖一、B. subtilis BCRC 14715於35°C發酵黑豆對血管收縮素轉化酶之抑制能力---------------------------------------------------------------------------- 69圖二、B. subtilis BCRC 14715於40°C發酵黑豆對血管收縮素轉化酶之抑制能力---------------------------------------------------------------------------- 70圖三、B. subtilis BCRC 14715於45°C發酵黑豆對血管收縮素轉化酶之抑制能力---------------------------------------------------------------------------- 71圖四、B. subtilis BCRC 14715於50°C發酵黑豆對血管收縮素轉化酶之抑制能力---------------------------------------------------------------------------- 72錄二、台灣農業化學與食品科學期刊格式------------------------------------------ 7
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Author-wise bibliometric analysis based on entropy.
Author-wise bibliometric analysis based on entropy.</p
- …
